文献速递银屑病与炎症性皮肤病

银屑病与认知、脑影像标志物及痴呆风险无关:鹿特丹研究

Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study.
PubMed 文献 · J Am Acad Dermatol · 2018-08-06

基于人群的鹿特丹研究纳入318例银屑病患者和9678例非银屑病参与者,比较认知功能、脑MRI标志物和痴呆风险。银屑病与认知测试评分、脑MRI指标及轻度认知障碍均无关联,且与痴呆风险降低相关(校正风险比0.50,95%CI 0.28-0.91)。

要点

  • 银屑病患者的认知测试评分与脑MRI体积、微结构及局灶指标与非银屑病参与者无差异。
  • 银屑病与轻度认知障碍无关联(校正比值比0.87,95%CI 0.53-1.43)。
  • 银屑病与痴呆风险降低相关(校正风险比0.50,95%CI 0.28-0.91)。

核心结论

  • 在这项基于人群的研究中,银屑病与临床前标志物或更高的痴呆风险无关。

研究设计与样本

  • 基于人群的鹿特丹研究,纳入318例银屑病患者和9678例非银屑病参与者(平均年龄66.1岁,58%为女性)。
  • 采用线性回归和逻辑回归分析银屑病与认知功能、轻度认知障碍及脑损伤MRI标志物的关联,采用Cox回归计算痴呆风险。

主要发现

  • 银屑病参与者(28%接受系统治疗和紫外线治疗)与非银屑病参与者的认知测试评分及脑MRI体积、微结构、局灶指标均无差异。
  • 银屑病与轻度认知障碍无关联(校正比值比0.87,95%CI 0.53-1.43)。
  • 随访115.000人年期间发生810例痴呆(银屑病患者中15例),校正混杂因素后银屑病与痴呆风险降低相关(校正风险比0.50,95%CI 0.28-0.91)。

局限性

  • 银屑病患者中痴呆病例有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Based on increased cardiometabolic comorbidities, inflammation, and an overlap in genetics with Alzheimer disease, psoriasis patients might be at risk for cognitive dysfunction and dementia. OBJECTIVE: To compare cognition, magnetic resonance imaging (MRI)-markers, and dementia risk in psoriasis and nonpsoriasis participants in the population-based Rotterdam Study. METHODS: We identified 318 psoriasis and 9678 nonpsoriasis participants (mean age 66.1 years, 58% women). The association of psoriasis with cognitive function, mild cognitive impairment, and MRI-markers of brain damage was examined by linear and logistic regression. Dementia risk was calculated using Cox regression. Models were adjusted for age, sex, education, and cardiovascular risk factors. RESULTS: Cognitive test scores and volumetric, microstructural, focal measures on brain MRI did not differ between psoriasis (28% systemic and ultraviolet treatment) and nonpsoriasis participants, and psoriasis was not associated with mild cognitive impairment (adjusted odd ratio 0.87, 95% confidence interval 0.53-1.43). During 115.000 person-years of follow-up, 810 incident dementia cases (15 among psoriasis patients) occurred. After adjusting for confounders, psoriasis was associated with a lower risk of developing dementia (adjusted hazard ratio 0.50, 95% confidence interval 0.28-0.91). LIMITATIONS: Limited dementia cases among psoriasis patients. CONCLUSION: In this population-based study, psoriasis was not associated with preclinical markers or higher dementia risk.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Pezzolo E, Mutlu U, Vernooij MW, et al. Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study. J Am Acad Dermatol. 2018. PMID: 30092331. doi:10.1016/j.jaad.2018.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。